Alexander Gibbs

Alexander Gibbs

Auto-generated profile, based on publicly available information

Alexander Gibbs

NHS North Thames Genomic Laboratory Hub Great Ormond Street Hospital for Children NHS Foundation Trust London UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2025 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
AGAlexander Gibbs
Alexander Gibbs
LSLavanya Sinha
Lavanya Sinha
AMAnna Marsh
Anna Marsh

30 August 2025 in Prenatal Diagnosis
Verified
Journal Article
Open access
VRVijaya Ramachandran
Vijaya Ramachandran
NCNatalie J. Chandler
Natalie J. Chandler
AGAlexander Gibbs
Alexander Gibbs
EWElspeth Whitby
Elspeth Whitby
RBRuth Braham
Ruth Braham
SMSarju G. Mehta
Sarju G. Mehta
Key Points: What's already known about this topic? What does this study add?

18 June 2026 in Prenatal Diagnosis
Verified
Journal Article
Open access
AGA. Gibbs
A. Gibbs
RBR. Braham
R. Braham
VRV. Ramachandran
V. Ramachandran
RRR. Roberts
R. Roberts
CWC. Willison
C. Willison
NCN. J. Chandler
N. J. Chandler
Objective: Prenatal sequencing of fetuses with abnormalities detected on imaging is expanding globally. Debate continues over whether variants of uncertain significance (VUS) should be reported prenatally, with some recent national position statements opposing this. In England, VUS that fit the fetal phenotype and require little further evidence for upgrade are discussed at multidisciplinary team (MDT) meetings to determine whether to report. We review the VUS reported by one English laboratory that provides prenatal sequencing to half of England. Method: The laboratory's database was searched from 01/10/2020 to 30/04/2025 to ascertain all cases where a VUS was reported. Pregnancy outcomes were obtained from local clinical teams to determine whether the VUS status had been resolved. Results: VUS were reported in 41/881 fetuses sequenced. Follow‐up data were available for 38/41 cases, of which 23 were subsequently upgraded to likely pathogenic and 1 downgraded to likely benign. The most common reason for upgrade was new information from post‐mortem or postnatal review (17/23). Conclusion: There is clinical utility in reporting VUS from prenatal sequencing following MDT discussion. Although reporting VUS leaves parents with uncertainty, follow up (including post‐mortem when applicable) resolves this in over 50% of cases (79% of cases re‐examined pre‐ or postnatally).

28 May 2025 in Prenatal Diagnosis
Verified
Journal Article
Open access
AGAlexander Gibbs
Alexander Gibbs
MHMuriel Holder‐Espinasse
Muriel Holder‐Espinasse
VRVijaya Ramachandran
Vijaya Ramachandran
NCNatalie J. Chandler
Natalie J. Chandler

30 May 2025 in Prenatal Diagnosis
Verified
Journal Article
Open access
LMLara Menzies
Lara Menzies
AGAlexander Gibbs
Alexander Gibbs
TATazeen Ashraf
Tazeen Ashraf
CBClare Beesley
Clare Beesley
RRRowenna Roberts
Rowenna Roberts
NCNatalie J. Chandler
Natalie J. Chandler